A long-term strategy for cancer services
Cancer survival rates in the UK lagged behind many western countries long before the pandemic. As attention turns to NHS recovery, Professor Gordon Wishart,...
The chance to get personal
Consumers are increasingly paying for their own genetic profiles and becoming aware of their health risks but who will step in to help them...
Investing in healthcare
After a subdued 2023, there are signs that deal activity is starting to gradually pick up in 2024. HM reports from LaingBuisson’s Annual Investing...
Beating the backlog
The Covid-19 pandemic has brought unprecedented pressures to healthcare systems across the world and for endoscopy, the backlog presented by postponed procedures could have...
Post-Covid rehab
There is still much unknown about the long-term health implications for patients who have had the most severe forms of Covid-19, but it is...
A new era for the Electronic Patient Record?
Money has been allocated to deliver on the Department of Health and Social Care’s mandate to have a fully digital health and social care...
The power of choice
Twenty years since it was introduced in the wake of spiralling NHS waits, patient choice remains poorly served by GPs and poorly understood by...
Boosting business
Independent consultant Richard Gregory discusses whether a new approach to pricing could help lift self-pay growth out of the doldrums
At the Private Healthcare Summit...
Adapting regulation for a health emergency
Covid-19 arrived swiftly and has spread rapidly, prompting the need for speed and agility never seen before in healthcare regulation. Rachel Cooper and Natasha...
Transparency: thrive not survive
Dr Clare Morgan, senior medical educator for MPS Partnerships, and Dr Rob Hendry, Medical Protection Society medical director, spoke at a joint MPS Partnerships-LaingBuisson...